Genetic risk for hospitalization of African American patients with severe mental illness reveals HLA loci.

"Conflict of interest KR has performed scientific consultation for Acer Therapeutics, Bickel, Bionomics, Boehringer Ingelheim, Takeda, and Jazz Pharma; serves on Scientific Advisory Boards for Sage, the Brain Research Foundation, and the National Center for PTSD, he has received sponsored research support from Brains way and Alto Neuroscience. He also receives research funding from the NIH and the Welcome Leap. ED receives or has received research support for work unrelated to this project from NIMH 1R01MH117315-01A1; 5R21MH117512-02, the Department of Veterans Affairs CSP2016; CSP590; MHBA-016-15S; 1I01CX000974-01A1, Auspex Pharmaceuticals, Inc. and Teva Pharmaceuticals, Inc. ED is a full-time attending psychiatrist in the Mental Health Service Line at the Atlanta Veterans Affairs Health Care System, Decatur, GA. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor GB declared a past co-authorship with author APW."

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was primarily supported by the National Institutes of Mental Health (R01 Mh071537 Genetic and Trauma-Related Risk Factors for PTSD)."